These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2083917)

  • 61. [What possibilities exist to modify cataract development on the basis of current biochemical knowledge? Where can drugs act?].
    Hockwin O
    Klin Monbl Augenheilkd; 1985 Jun; 186(6):455-61. PubMed ID: 4046454
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Conservative management of senile cataract with conjunctisan A eye drops].
    Fuchs J
    Klin Monbl Augenheilkd; 1979 Dec; 175(6):799-805. PubMed ID: 552005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Results of clinical studies on drug modification of progressive lens opacities].
    Weigelin E
    Klin Monbl Augenheilkd; 1985 Jun; 186(6):462-7. PubMed ID: 3900541
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A model of diffusion of anti-cataract drugs into the lens tissue].
    Chasovnikova LV; Formaziuk VE; Sergienko VI; Vlasimirov IuA
    Biofizika; 1990; 35(3):464-8. PubMed ID: 2207189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical aspects and experimental findings in so-called senile cataracts. Determination of status].
    Pau H; Hockwin O; Eckerskorn U
    Klin Monbl Augenheilkd; 1988 Jun; 192(6):677-85. PubMed ID: 3062247
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
    Abdelkader H; Alany RG; Pierscionek B
    J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pharmacological means to prevent secondary cataract].
    Rabsilber TM; Auffarth GU
    Klin Monbl Augenheilkd; 2006 Jul; 223(7):559-67. PubMed ID: 16855938
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cataract prevention. Therapeutic approaches and critical review of current status].
    Wegener A
    Ophthalmologe; 2003 Mar; 100(3):176-80. PubMed ID: 12640545
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological treatment strategies in age-related cataracts.
    Harding JJ
    Drugs Aging; 1992; 2(4):287-300. PubMed ID: 1504443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The worth of anti-cataract drugs].
    Hockwin O; Schmitt C
    Fortschr Ophthalmol; 1990; 87 Suppl():S9-13. PubMed ID: 2083917
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.